NCT07525245 is a NA clinical trial of Scientific videos in HPV Vaccination Rates, sponsored by Xiamen University.

Who is sponsoring NCT07525245?

NCT07525245 is sponsored by Xiamen University.

What drugs are being tested in NCT07525245?

Interventions in NCT07525245: Scientific videos, Vaccine chatbot.

What condition does NCT07525245 study?

NCT07525245 studies HPV Vaccination Rates, HPV Vaccine Awareness, HPV Vaccination Intention.

Is NCT07525245 still recruiting?

NCT07525245 is currently not yet recruiting. Last updated 15 April 2026.

Last reviewed 2026-04-15 · How we verify

NCT07525245

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Effectiveness of Large Language Model-Based Chatbot Among Parents of Junior High School Girls in Improving Human Papillomavirus (HPV) Vaccine Awareness, Intention and Vaccination Rates

Not yet recruiting NA Last updated 15 April 2026

What this trial tests

NA trial testing Scientific videos in HPV Vaccination Rates in 18,000 participants. Not yet recruiting.

Timeline

6 May 2026

Primary endpoint
31 December 2027

31 December 2027

Quick facts

Lead sponsor	Xiamen University
Phase	NA
Status	Not yet recruiting
Study type	INTERVENTIONAL
Allocation	randomized
Design	parallel
Masking	none
Primary purpose	health services research
Enrollment	18,000
Start date	6 May 2026
Primary completion	31 December 2027
Estimated completion	31 December 2027

Drugs / interventions tested

Scientific videos
Vaccine chatbot

Conditions studied

HPV Vaccination Rates — all drugs for HPV Vaccination Rates →
HPV Vaccine Awareness — all drugs for HPV Vaccine Awareness →
HPV Vaccination Intention — all drugs for HPV Vaccination Intention →

Sponsor

Xiamen University

Who can join

Eligibility, any sex, with HPV Vaccination Rates or HPV Vaccine Awareness. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

This is an interventional study targeting parents of junior high school girls. The primary objective of the study is to evaluate the effectiveness of a vaccine chatbot in improving HPV vaccination rates among parents' junior high school girls. The secondary objectives are to evaluate the effectiveness in improving vaccine awareness and vaccination intention among parents. All participants will be enrolled and randomly assigned to four groups: (1) vaccine chatbot plus scientific videos, (2) vaccine chatbot only, (3) scientific videos only, and (4) a control group (no intervention). The chatbot will provide immediate, validated answers to participants' HPV vaccine-related questions. The scientific videos will cover content related to HPV vaccine safety, efficacy, and other relevant information. The study will compare changes in HPV vaccine awareness, vaccination intention, and vaccination behavior between the intervention groups and the control group after the intervention to evaluate whether the three intervention strategies enhance HPV vaccine awareness, vaccination intention, and vaccination uptake.

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other Xiamen University trials

Trials by the same sponsor.

NCT07351604 — Effectiveness of Large Language Model-Based Chatbot Among Female University Stdents in Improving HPV Vaccine Awareness, · NA · not yet recruiting
NCT06866574 — A Phase III Trial to Evaluate the Efficacy, Immunogenicity and Safety of a Recombinant Human Papillomavirus 9-Valent (Ty · Phase 3 · active not recruiting
NCT06243666 — Long-term Effectiveness and Immuno-persistence Study of a Recombinant HPV 16/18 Bivalent Vaccine in Preadolescent Girls · active not recruiting
NCT06197802 — Plateau Antibody Levels of a Recombinant (E.Coli) HPV Nonavalent Vaccine Versus Gardasil®9 in Young Women · active not recruiting
NCT05976594 — Long-term Effectiveness of a Recombinant Hepatitis E Vaccine · unknown

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT07525245 (US National Library of Medicine, public domain)
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Xiamen University
Last refreshed: 15 April 2026

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT07525245.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing